glp-1 anesthesia guidelines 2025 RA guidance roundup Perioperative Management of GLP-1 Receptor
Description
Diabetes 68(Supplement 1):123-OR Wang C, Li L, Liu S, Liao G, Li L, Chen Y et al (2018) GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis
Patients may benefit from evaluation if they have obesity, have overweight with related medical conditions, have struggled with weight loss despite lifestyle changes, or want medically supervised treatment options
The company made this prediction on the timing of FDA approval as it announced top-line results of a Phase 3 study showing a nearly 16% overall weight loss over a 17-month period among people who have both Type 2 diabetes and obesity 1
Research is ongoing into whether GLP-1s exert a direct effect on adipocytes or whether this is a consequence of rapid systemic weight loss alone
Cardiovascular health: Diet quality, fiber intake, and exercise strongly influence heart health
